US Prescription Drug Sales Tumbled In 2008
Posted on: Friday, 20 March 2009, 07:40 CDT
Sales of prescription drugs in the United States rose a paltry 1.3 percent last year, as patients sought cheaper generic versions of their medications or went without treatment altogether due to the economic slowdown.
The data reflects a continuation of a slowdown in U.S. sales of prescription drugs in recent years. In 2007, prescription drugs sales in the U.S. rose 3.8 percent. In 2006 the number was roughly 8 percent. However, even those years were less than the double-digit annual percentage sales growth seen in previous decades.
The troublesome news comes from information supplied by IMS Health Inc., which compiles pharmaceutical industry market data.
"Dispensed prescription volume in the United States grew at a 0.9 percent pace" in 2008, a Reuters report quoted the IMS as saying.
Previous IMS reports placed the dispensed volume growth at 2.8 percent in 2007 and 4.6 percent in 2006.
In its current report, IMS predicted that U.S. prescription drug sales would climb 1 to 2 percent in 2009. However, the company did not provide an updated sales forecast in its media advisory.
Lipid drugs, those that lower "bad" LDL cholesterol and triglycerides or raise "good" HDL cholesterol, were at the top of the list last year of dispensed U.S. retail prescription drugs on a volume basis, according to IMS. These were followed by codeine and other drugs containing the narcotic painkiller, anti-depressants and two types of blood pressure medications known as ACE inhibitors and beta blockers.
"In terms of overall prescription sales through both retail and non-retail channels, antipsychotics led all therapy classes," followed by lipid regulators, a popular class of ulcer and heartburn drugs known as proton pump inhibitors (PPIs) and anti-seizure medicines, IMS told Reuters.
In parallel with slowing sales growth in the United States, three large drugmakers are bracing for patent expirations on some of their top selling drugs in 2011, leaving them vulnerable to competition from lower-cost versions.
The firms include Pfizer Inc. with its $12 billion-a-year Lipitor cholesterol drug, Bristol-Myers Squibb Co with its Plavix blood clot prevention drug, and Eli Lilly & Co with its Zyprexa schizophrenia treatment.
Some analysts worry that U.S. sales of prescription drugs could suffer even more if President Obama and the Democratic-led Congress decides to require drugmakers to negotiate prices of their branded products.
The United States is currently the only major industrialized nation without price regulations for prescription drugs, making the country the world's most profitable market for medicines.
---
On the Net:
Source: redOrbit Staff & Wire Reports
Related Articles
- Ford of Europe Reports Strong September Sales to Break 10 Percent Market Share Barrier
- Essilor Acquires Prescription Laboratories in the United Kingdom and the United States
- Report Provides the Information and Analysis You Need on Cvs and Pharmacare Management Services to Gain an Understanding of What Makes the Company One of the Leading Drug Retailers
- Firm: US Drug Sales Will Fall 17 Percent
- Itronics Reports 47 Percent Increase in GOLD'N GRO Fertilizer Division Fourth Quarter Sales; Increase of 39 Percent in 2006
- Retail Sales Rise Nearly 10 Percent
- U.S. Retail Sales in Dec. Up 0.7 Percent
- Nearly 50 Percent of Online Retailers Will Switch Their eCommerce Platform Within Two Years
- Petrol Sales Fall By 11 Percent in Belgium
- Nokia quarterly cellphone sales down ; Could be 9 percent below expectations
 |
 |
User Comments (1)
| 1. |
Posted by Daniel Haszard on 03/20/2009, 08:14 Please do a report on how Lilly's (NOW $4.6 billion) propaganda payout is a fraud,as a matter of fact 8 Lilly employees who are supposed 'whistleblowers' are getting $ 10 mill each the real victims like me are being ignored Zyprexa claims being stonewalled Where is the (now up to) $4.6 billion Eli Lilly Zyprexa settlement going as many victim claimants haven't been paid yet? It's the largest pharma-fraud-whistleblower case in US history. Daniel Haszard http://www.zyprexa-victims.com |
RSS Feeds